The 2019 € 100.000 Award will be dedicated to the promotion and recognition of excellence in orphan disease treatment research
What is this Prize about?
The 2019 € 100.000 Award will be dedicated to the promotion and recognition of excellence in orphan disease treatment research.
Which kind of projects?
International projects within the area of rare/orphan disease treatment in all therapeutic areas (except for oncology, hematology and immunology) are eligible to apply as long as the disease concerned has a prevalence of not more than 1 in 2000.
Who can apply?
The 2019 Award is open to researchers of all nationalities who are not in any way directly affiliated with pharmaceutical or medical device companies.
2019 Review Committee /Members of the Jury:
Applications will be reviewed by an independent panel of internationally recognized experts who have provided leadership throughout their long careers in the field of Rare Diseases.
Professor Robert J. Desnick, Ph.D., M.D., Dean for Genetic and Genomic Medicine, Professor and Chair Emeritus Department of Genetic & Genomic Sciences, Mount Sinai School of Medicine, New York, USA.
Professor Francesco Emma M.D., Director of the Division of Pediatric Nephrology, Chief of the Department of Pediatric Subspecialties, IRCCS Children’s Hospital Bambino Gesù, Rome, Italy
Professor Norio Sakai, M.D., Ph.D., Child Healthcare and Genetic Science Laboratory, Division of Health Science, Osaka University Graduate School of Medicine, Osaka, Japan.
Deadline for the submission
Nominations procedure will follow a two-step selection approach:
Deadline of the preselection: 15th December 2018
Full Applications: 30th April 2019.
For eligibility and exclusion criteria of the 2019 Award and to submit an Application
prize.recordati.it
Contacts: recordati.prize2019@recordati.com
VoltarCONTACTOS
Faculdade de Farmácia da U.L.
Av. Prof. Gama Pinto
1649-003 Lisboa
Portugal
Contacto: Fernanda Asper
Telefone.: +351 217 946 400
(Chamada para a rede fixa nacional)
Fax: +351 217 946 491
spdm@ff.ul.pt
Subscreva a newsletter da SPDM - Sociedade Portuguesa de Doenças Metabólicas
Newsletter